A landscape of driver mutations in melanoma

Hodis, Eran, Watson, Ian R., Kryukov, Gregory V., Arold, Stefan T., Imielinski, Marcin, Theurillat, Jean-Philippe, Nickerson, Elizabeth, Auclair, Daniel +32 more·2012·Cell
DOI 10.1016/j.cell.2012.06.024

Cited by (1,006)

Items 301–400 of 1,006

  1. Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis
    Hao Jiang, Hui‐Jun Cao, Ning Ma, Wen-Dai Bao, Jingjing Wang, Tianwei Chen, Er‐Bin Zhang, Yanmei Yuan, Qian‐Zhi Ni, Feng-Kun Zhang et al. · 2020 · Proceedings of the National Academy of Sciences
  2. Overcoming resistance to BRAF inhibition in BRAF-mutated metastatic melanoma
    Francesco Spagnolo, Paola Ghiorzo, Paola Queirolo · 2014 · Oncotarget
  3. Epidemiology, Risk Factors, Prevention, and Early Detection of Melanoma
    Said Charbel Azoury, Julie R. Lange · 2014 · Surgical Clinics of North America
  4. Cancer epigenetics: Past, present and future
    Jae Eun Lee, Mi‐Young Kim · 2021 · Seminars in Cancer Biology
  5. Genome-wide identification and analysis of prognostic features in human cancers
    Joan C. Smith, Jason M. Sheltzer · 2022 · Cell Reports
  6. Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
    Harshita B. Gupta, Curtis A. Clark, Bin Yuan, Gangadhara R. Sareddy, Srilakshmi Pandeswara, Alvaro Souto Padron, Vincent J. Hurez, Jose Ramon Conejo-Garcia, Ratna K. Vadlamudi, Rong Li et al. · 2016 · Signal Transduction and Targeted Therapy
  7. Melanocyte Stem Cell Activation and Translocation Initiate Cutaneous Melanoma in Response to UV Exposure
    Hyeongsun Moon, Leanne R. Donahue, Eun-Ju Choi, Philip O. Scumpia, William E. Lowry, Jennifer K. Grenier, Jerry Zhu, Andrew C. White · 2017 · Cell stem cell
  8. KIT and Melanoma: Biological Insights and Clinical Implications
    Duc Daniel M. Pham, Samantha M. Guhan, Hensin Tsao · 2020 · Yonsei Medical Journal
  9. CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features
    Yong Mao, Han Chen, Han Liang, Funda Meric‐Bernstam, Gordon Brent Mills, Ken Chen · 2013 · PLoS ONE
  10. Targeted therapy for melanoma: rational combinatorial approaches
    Lawrence N. Kwong, Michael A. Davies · 2013 · Oncogene
  11. TERT promoter mutations in melanoma survival
    Eduardo Nagore, Barbara Heidenreich, P. Sivaramakrishna Rachakonda, Zaida García‐Casado, Celia Requena, Virtudes Soriano, Christoph Frank, Víctor Traves, Esther Quecedo, Josefa Sanjuan‐Gimenez et al. · 2016 · International Journal of Cancer
  12. Landscape of Combination Immunotherapy and Targeted Therapy to Improve Cancer Management
    Leandro Machado Colli, Mitchell J. Machiela, Han Zhang, Timothy A. Myers, Lea Jessop, Olivier Delattre, Kai F. Yu, Stephen Jacob Chanock · 2017 · Cancer Research
  13. Naturally Occurring Canine Melanoma as a Predictive Comparative Oncology Model for Human Mucosal and Other Triple Wild-Type Melanomas
    Belen Hernandez, Hibret A. Adissu, Bih‐Rong Wei, Helen Michael, Glenn T Merlino, R. Mark Simpson · 2018 · International Journal of Molecular Sciences
  14. TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours
    Klaus Griewank, Rajmohan Murali, Bastian Schilling, Simone L. Scholz, Antje Sucker, Mingxia Song, Daniela Süßkind, Florian Grabellus, Lisa Zimmer, Uwe Hillen et al. · 2013 · British Journal of Cancer
  15. Allosteric MEK1/2 inhibitors including cobimetanib and trametinib in the treatment of cutaneous melanomas.
    R. Roskoski · 2017 · Pharmacological Research
  16. Mutation frequencies of GNAQ, GNA11, BAP1, SF3B1, EIF1AX and TERT in uveal melanoma: detection of an activating mutation in the TERT gene promoter in a single case of uveal melanoma
    Mariella Dono, Giovanna Angelini, Maurizio Cecconi, Adriana Agnese Amaro, A I Esposito, Valentina Mirisola, Irena Maric, Francesco Baldo Lanza, Francesca Nasciuti, Silvia Viaggi et al. · 2014 · British Journal of Cancer
  17. Cutaneous melanoma
    Alpaslan Tasdogan, Ryan Joseph Sullivan, Alexander Katalinic, Célèste Lebbé, Dagmar Whitaker, Susana Puig, Lonneke Veronique van de Poll-Franse, Daniela Massi, Dirk Schadendorf · 2025 · Nature Reviews Disease Primers
  18. Ocular Adverse Events Associated with Mek Inhibitors
    Méndez-Martínez, Silvia, Calvo, Pilar, Ruiz-Moreno, Oscar, Pardiñas Barón, Nieves, Leciñena Bueno, Jesús, Gil Ruiz, María del Rocío, Pablo, Luis · 2019 · Retina
  19. Epigenomic regulation of oncogenesis by chromatin remodeling
    Rakesh Kumar, D-Q Li, Susanne Müller, Stefan Knapp · 2016 · Oncogene
  20. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
    J. Saunus, M. Quinn, A. Patch, John V. Pearson, P. Bailey, K. Nones, A. McCart Reed, David Miller, P. Wilson, F. Al-Ejeh et al. · 2015 · Journal of Pathology
  21. Mediator kinase module and human tumorigenesis
    Alison D. Clark, Marieke Oldenbroek, Thomas Boyer · 2015 · Critical Reviews in Biochemistry and Molecular Biology
  22. The Case for Proteomics and Phospho‐Proteomics in Personalized Cancer Medicine
    Sophia Doll, Florian Gnad, Matthias Mann · 2019 · PROTEOMICS - CLINICAL APPLICATIONS
  23. Analysis of Mucosal Melanoma Whole-Genome Landscapes Reveals Clinically Relevant Genomic Aberrations
    Rong Zhou, Chaoji Shi, Wenjie Tao, Jiang Li, Jing Wu, Yong Han, Guizhu Yang, Ziyue Gu, Shengming Xu, Yujue Wang et al. · 2019 · Clinical Cancer Research
  24. Sema3C Promotes the Survival and Tumorigenicity of Glioma Stem Cells through Rac1 Activation
    Jianghong Man, Jocelyn D. Shoemake, Wenchao Zhou, Xiaoguang Fang, Qiulian Wu, Anthony E. Rizzo, Richard A. Prayson, Shideng Bao, Jeremy N. Rich, Jennifer S. Yu · 2014 · Cell Reports
  25. Novel algorithmic approach predicts tumor mutation load and correlates with immunotherapy clinical outcomes using a defined gene mutation set
    Jason Roszik, Lauren Elaine Haydu, Kenneth R. Hess, Junna Oba, Aron Y. Joon, Alan E. Siroy, Tatiana V. Karpinets, Francesco C. Stingo, Veera Baladandayuthapani, Michael T. Tetzlaff et al. · 2016 · BMC Medicine
  26. Updates of reactive oxygen species in melanoma etiology and progression
    Feng Liu, Ryan W. Dellinger, Frank Louis Meyskens · 2014 · Archives of Biochemistry and Biophysics
  27. Mdm2 and aurora kinase a inhibitors synergize to block melanoma growth by driving apoptosis and immune clearance of tumor cells
    Vilgelm, Anna E., Pawlikowski, Jeff S., Liu, Yan, Hawkins, Oriana E., Davis, Tyler A., Smith, Jessica, Weller, Kevin P., Horton, Linda W., McClain, Colt M., Ayers, Gregory D. et al. · 2015 · Cancer Research
  28. Challenges and Opportunities in the Development of Protein Phosphatase-Directed Therapeutics
    Sofie De Munter, Maja Köhn, Mathieu Bollen · 2012 · ACS Chemical Biology
  29. VarWalker: Personalized Mutation Network Analysis of Putative Cancer Genes from Next-Generation Sequencing Data
    Peilin Jia, Zhongming Zhao · 2014 · PLoS Computational Biology
  30. Protein phosphatases in the regulation of mitosis
    Jakob Nilsson · 2018 · The Journal of Cell Biology
  31. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features
    Andrés Lanzós, Joana Carlevaro-Fita, Loris Mularoni, Ferrán Reverter, Emilio Palumbo, Roderic Guigó, Rory Johnson · 2017 · Scientific Reports
  32. p53/p63/p73 in the Epidermis in Health and Disease
    Vladimir A. Botchkarev, Elsa Renee Flores · 2014 · Cold Spring Harbor Perspectives in Medicine
  33. Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment
    Chenfei Zhou, Yanmei Zhang, Rui-Ming Yan, Lei Huang, Andrew L. Mellor, Yang Yang, Xiaojing Chen, Wen-Fei Wei, Xiang‐Guang Wu, Lan Yu et al. · 2020 · Cell Death and Differentiation
  34. Cyclic AMP (cAMP) signaling in melanocytes and melanoma
    Carlos Iván Rodríguez, Vijayasaradhi Setaluri · 2014 · Archives of Biochemistry and Biophysics
  35. Beyond BRAF: where next for melanoma therapy?
    Inna V. Fedorenko, G. Gibney, V. Sondak, K. Smalley · 2014 · British Journal of Cancer
  36. Human αβ and γδ T Cells in Skin Immunity and Disease
    Michelle S. Cruz, Alani Diamond, Astrid Russell, Julie Jameson · 2018 · Frontiers in Immunology
  37. Emerging molecular targets in melanoma invasion and metastasis
    José Luis Orgaz, Victoria Sanz‐Moreno · 2012 · Pigment Cell & Melanoma Research
  38. Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights
    Gongda Xue, Emanuela Romano, Daniela Massi, Mario Mandalà · 2016 · Cancer Treatment Reviews
  39. MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases
    Xue Li Bai, Yan Kong, Zhihong Chi, Xinan Sheng, Chuanliang Cui, Xuan Wang, Lili Mao, Bixia Tang, Siming Li, Bin Lian et al. · 2017 · Clinical Cancer Research
  40. Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
    Felicity Newell, Peter A. Johansson, James S. Wilmott, Kátia Nones, Vanessa Lakis, Antonia L. Pritchard, Serigne Lo, Robert V. Rawson, Stephen H. Kazakoff, Andrew J. Colebatch et al. · 2022 · Cancer Discovery
  41. Mechanisms of Drug Resistance in Melanoma
    Matthew L. Winder, Amaya Virós · 2017 · Handbook of experimental pharmacology
  42. Biology of Melanoma
    Stephen M. Ostrowski, David E. Fisher · 2020 · Hematology/Oncology Clinics of North America
  43. MC1R signaling. Intracellular partners and pathophysiological implications
    Cecilia Herráiz, José Carlos García-Borrón, Celia Jiménez‐Cervantes, Concepción Olivares · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  44. Rho GTPases as therapeutic targets in cancer (Review)
    Georgina Alexandra Cardama, Nazareno González, Julián Maggio, Pablo Lorenzano Menna, Daniel Eduardo Gomez · 2017 · International Journal of Oncology
  45. Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes
    Jarish N. Cohen, Nancy M. Joseph, Jeffrey P. North, Courtney S. Onodera, Artur Zembowicz, Philip E. LeBoit · 2017 · The American Journal of Surgical Pathology
  46. The Role of Altered Nucleotide Excision Repair and UVB-Induced DNA Damage in Melanomagenesis
    Timothy Budden, Nikola A. Bowden · 2013 · International Journal of Molecular Sciences
  47. Recurrent inactivating RASA2 mutations in melanoma
    Arafeh, Rand, Qutob, Nouar, Emmanuel, Rafi, Keren-Paz, Alona, Madore, Jason, Elkahloun, Abdel, Wilmott, James S, Gartner, Jared J, Di Pizio, Antonella, Winograd-Katz, Sabina et al. · 2015 · Nature Genetics
  48. Current State of Animal (Mouse) Modeling in Melanoma Research
    Omer F. Kuzu, Felix D. Nguyen, Mohammad A. Noory, Arati K. Sharma · 2015 · Cancer Growth and Metastasis
  49. Targeting senescence as an anticancer therapy
    Laura Bousset, Jesús Gil · 2022 · Molecular Oncology
  50. A reversible gene trap collection empowers haploid genetics in human cells
    Tilmann Bürckstümmer, Carina Banning, Philipp Hainzl, Richard Schobesberger, Claudia Kerzendorfer, Florian M. Pauler, Doris Chen, Nicole C.C. Them, Fiorella Schischlik, Manuele Rebsamen et al. · 2013 · Nature Methods
  51. Mutationally activated Rho GTPases in cancer
    Jamie K. Alan, Erik A. Lundquist · 2013 · Small GTPases
  52. RAC1 Takes the Lead in Solid Tumors
    Pradip K. De, Jennifer Carlson Aske, Nandini Dey · 2019 · Cells
  53. DrugMap: A quantitative pan-cancer analysis of cysteine ligandability
    Mariko Takahashi, Harrison Byron Chong, Siwen Zhang, Tzu-yi Yang, Matthew J. Lazarov, Stefan Andrew Harry, Michelle Maynard, Brendan J. Hilbert, Ryan D. White, Heather E. Murrey et al. · 2024 · Cell
  54. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation
    Paul W. Harms, Angela M. B. Collie, Daniel H. Hovelson, Andi K. Cani, Monique Elise Verhaegen, Rajiv M. Patel, Douglas Randall Fullen, Kei Omata, Andrzej Antoni Dlugosz, Scott A. Tomlins et al. · 2016 · Modern Pathology
  55. Focus on cutaneous and uveal melanoma specificities
    Charlotte Pandiani, Guillaume E. Béranger, Justine Leclerc, Robert Ballotti, Corine Bertolotto · 2017 · Genes & Development
  56. Correlation of BRAF and NRAS mutation status with outcome, site of distant metastasis and response to chemotherapy in metastatic melanoma
    M. Carlino, L. Haydu, H. Kakavand, A. Menzies, Anne Hamilton, Bing Yu, C. Ng, Wendy A. Cooper, John F. Thompson, R. Kefford et al. · 2014 · British Journal of Cancer
  57. EZH2: Not EZHY (Easy) to Deal
    Gauri Deb, Anup Kumar Singh, Sanjay Gupta · 2014 · Molecular Cancer Research
  58. An epigenetic gateway to brain tumor cell identity
    Stephen C. Mack, Christopher G. Hubert, Tyler E. Miller, Michael D. Taylor, Jeremy N. Rich · 2015 · Nature Neuroscience
  59. Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma
    Katja Harbst, Martin Lauss, Helena Cirenajwis, Karolin Isaksson, Frida Rosengren, Therese Törngren, Anders Kvist, Maria C. Johansson, Johan Vallon‐Christersson, Bo Baldetorp et al. · 2016 · Cancer Research
  60. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42
    Meredith Stevers, Joseph T. Rabban, Karuna Garg, Jessica Van Ziffle, Courtney S. Onodera, James P. Grenert, Iwei Yeh, Boris C. Bastian, Charles J. Zaloudek, David A. Solomon · 2018 · Modern Pathology
  61. Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive transfer with tumor-infiltrating lymphocytes in melanoma
    Nikolaj Pagh Kristensen, Christina Heeke, Siri Amanda Tvingsholm, Annie Borch, Arianna Draghi, Michael Douglas Crowther, Ibel Carri, Kamilla Kjærgaard Munk, Jeppe Sejerø Holm, Anne-Mette Bjerregaard et al. · 2021 · UCL Discovery (University College London)
  62. Regulation and function of P-Rex family Rac-GEFs
    Heidi C. E. Welch · 2015 · Small GTPases
  63. Unraveling the clonal hierarchy of somatic genomic aberrations
    Davide Prandi, Sylvan C. Baca, Alessandro Romanel, Christopher E. Barbieri, Juan‐Miguel Mosquera, Jacqueline Fontugne, Himisha Beltran, Andrea Sboner, Levi A. Garraway, Mark A. Rubin et al. · 2014 · Genome biology
  64. The clinical significance ofBRAFandNRASmutations in a clinic-based metastatic melanoma cohort
    Henrik Ekedahl, Helena Cirenajwis, Katja Harbst, Ana Carneiro, Kari Nielsen, Hakan Lars Olsson, Lotta Lundgren, Christian Ingvar, Goran G. Jonsson · 2013 · British Journal of Dermatology
  65. Genetics of metastasis: melanoma and other cancers
    Noel Turner, Olivia R. Ware, Marcus Bosenberg · 2018 · Clinical & Experimental Metastasis
  66. MC1R: Front and Center in the Bright Side of Dark Eumelanin and DNA Repair
    Viki B. Swope, ZALFA A. ABDEL‐MALEK · 2018 · International Journal of Molecular Sciences
  67. SOX10 Ablation Arrests Cell Cycle, Induces Senescence, and Suppresses Melanomagenesis
    Julia C. Cronin, Dawn E. Watkins‐Chow, Arturo A. Incao, Joanne H. Hasskamp, Nicola Schönewolf, Lauren G. Aoude, Nicholas K. Hayward, Boris C. Bastian, Reinhard Dummer, Stacie K. Loftus et al. · 2013 · Cancer Research
  68. Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets
    Giuseppe Palmieri, Maria Neve Ombra, Maria Colombino, Milena Casula, Maria Cristina Sini, Antonella Manca, Panagiotis Paliogiannis, Paolo A. Ascierto, Antonio Cossu · 2015 · Frontiers in Oncology
  69. Small Rho GTPases in the control of cell shape and mobility
    Arun Murali, K. Rajalingam · 2013 · Cellular and Molecular Life Sciences
  70. Activating the Wnt/β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3
    Jennifer M. Atkinson, Kenneth B. Rank, Yi Arial Zeng, Andrew R. Capen, Vipin Yadav, Jason R. Manro, Thomas A. Engler, Marcio Chedid · 2015 · PLoS ONE
  71. Oncogenic BRAFV600E Governs Regulatory T-cell Recruitment during Melanoma Tumorigenesis
    Tamer Basel Shabaneh, Aleksey K. Molodtsov, Shannon M. Steinberg, Peisheng Zhang, Gretel M. Torres, Gadisti Aisha Mohamed, Andrea Boni, Tyler Jay Curiel, Christina Vadala Angeles, Mary Jo Turk · 2018 · Cancer Research
  72. Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma
    Amanda Dawn Bucheit, Erica Syklawer, John Andrew Jakob, Roland L. Bassett, Jonathan L. Curry, Jeffrey E. Gershenwald, Kevin B. Kim, Patrick Hwu, Alexander J. Lazar, Michael A. Davies · 2013 · Cancer
  73. A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs
    Derrick S. Haslem, S. Burke Van Norman, Gail Fulde, Andrew J. Knighton, Tom Belnap, Allison M. Butler, Sharanya Rhagunath, David M. Newman, Heather Gilbert, Brian P. Tudor et al. · 2016 · Journal of Oncology Practice
  74. GNAQ and GNA11 Genes: A Comprehensive Review on Oncogenesis, Prognosis and Therapeutic Opportunities in Uveal Melanoma
    Paula Silva, Daniel Fernández‐Díaz, Manuel F. Bande, María Pardo, Lourdes Loidi, María José Blanco‐Teijeiro · 2022 · Cancers
  75. Circulating Tumor DNA as an Early Indicator of Response to T-cell Transfer Immunotherapy in Metastatic Melanoma
    Liqiang Xi, Trinh Hoc-Tran Pham, Eden C. Payabyab, Richard Mark Sherry, Steven A. Rosenberg, Mark A. Raffeld · 2016 · Clinical Cancer Research
  76. Rho GTPases: Anti- or pro-neoplastic targets?
    Inuk Zandvakili, Yiwei Lin, J C Morris, Yunfei Zheng · 2016 · Oncogene
  77. Emergence of ERBB2 Mutation as a Biomarker and an Actionable Target in Solid Cancers
    Janakiraman Subramanian, Archana Katta, Ashiq Masood, Dashavantha Reddy Vudem, Rama Krishna Kancha · 2019 · The Oncologist
  78. Navigating the Therapeutic Complexity of PI3K Pathway Inhibition in Melanoma
    Lawrence N. Kwong, Michael A. Davies · 2013 · Clinical Cancer Research
  79. Function and regulation of the Rho guanine nucleotide exchange factor Trio
    Susanne Schmidt, Anne Debant · 2014 · Small GTPases
  80. Rho GTPases, their post-translational modifications, disease-associated mutations and pharmacological inhibitors
    Michael F. Olson · 2016 · Small GTPases
  81. Targeting Adenosine in BRAF-Mutant Melanoma Reduces Tumor Growth and Metastasis
    Arabella Young, Shin Foong Ngiow, Jason Madore, Julia Reinhardt, Jennifer Landsberg, Arash Chitsazan, Jai Rautela, Tobias Bald, Deborah Sim Barkauskas, Elizabeth Stephanie Ahern et al. · 2017 · Cancer Research
  82. Frequent Genetic Aberrations in the CDK4 Pathway in Acral Melanoma Indicate the Potential for CDK4/6 Inhibitors in Targeted Therapy
    Yan Kong, Xinan Sheng, Xiaowen Wu, Junya Yan, Meng Ma, Jiayi Yu, Lu Si, Zhihong Chi, Chuanliang Cui, Jie Dai et al. · 2017 · Clinical Cancer Research
  83. WWOX at the crossroads of cancer, metabolic syndrome related traits and CNS pathologies
    C. Marcelo Aldaz, Brent W. Ferguson, Martı́n C. Abba · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  84. Understanding genomic alterations in cancer genomes using an integrative network approach
    Edwin Wang · 2012 · Cancer Letters
  85. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
    Ke-Sin Yan, Chia‐Yuan Lin, Tan-Wei Liao, Cheng-Ming Peng, Shou-Chun Lee, Yi‐Jui Liu, Wing Pong Chan, Ruey‐Hwang Chou · 2017 · International Journal of Molecular Sciences
  86. Treatment-driven tumour heterogeneity and drug resistance: Lessons from solid tumours
    Stefania Crucitta, Federico Cucchiara, Ron H.J. Mathijssen, Joaquı́n Mateo, Agnes Jager, Arjen Joosse, Antonio Passaro, Ilaria Attili, Iacopo Petrini, Ron HN van Schaik et al. · 2022 · Cancer Treatment Reviews
  87. Functional variomics and network perturbation: connecting genotype to phenotype in cancer
    S. Stephen Yi, Shengda Lin, Yongsheng Li, Wei Zhao, Gordon Brent Mills, Nidhi Sahni · 2017 · Nature Reviews Genetics
  88. Photocarcinogenesis and Skin Cancer Prevention Strategies: An Update.
    M. Martens, C. Seebode, J. Lehmann, S. Emmert · 2018 · Anticancer Research
  89. miR-514a regulates the tumour suppressor NF1 and modulates BRAFi sensitivity in melanoma
    Mitchell S. Stark, Vanessa Bonazzi, Glen M. Boyle, Jane M. Palmer, Judith Symmons, Catherine M. Lanagan, Christopher Schmidt, Adrian C. Herington, Robert Ballotti, Pamela M. Pollock et al. · 2015 · Oncotarget
  90. Cell Cycle Deregulation and TP53 and RAS Mutations Are Major Events in Poorly Differentiated and Undifferentiated Thyroid Carcinomas
    Jaime Miguel Gomes Pita, Ines Figueiredo, Margarida M. Moura, Valeriano Alberto Pais Horta Leite, Branca Maria Cavaco · 2014 · The Journal of Clinical Endocrinology & Metabolism
  91. Simulating Next-Generation Sequencing Datasets from Empirical Mutation and Sequencing Models
    Zachary D. Stephens, Matthew E. Hudson, Liudmila Sergeevna Mainzer, Morgan L. Taschuk, Matthew Weber, Ravishankar K. Iyer · 2016 · PLoS ONE
  92. Advanced Melanoma: Current Treatment Options, Biomarkers, and Future Perspectives
    Elisa A. Rozeman, Tim J. A. Dekker, John B.A.G. Haanen, Christian U. Blank · 2017 · American Journal of Clinical Dermatology
  93. A Review of Epidemiology and Cancer Biology of Malignant Melanoma
    Matthew Gerard Davey, Nicola Miller, Niall M. McInerney · 2021 · Cureus
  94. A temporal perspective for tumor-associated macrophage identities and functions
    Camille Blériot, Garett Dunsmore, Direna Alonso‐Curbelo, Florent Ginhoux · 2024 · Cancer Cell
  95. A Meta-analysis of Somatic Mutations from Next Generation Sequencing of 241 Melanomas: A Road Map for the Study of Genes with Potential Clinical Relevance
    Xia, Junfeng, Jia, Peilin, Hutchinson, Katherine E., Dahlman, Kimberly B., Johnson, Douglas, Sosman, Jeffrey, Pao, William, Zhao, Zhongming · 2014 · Molecular Cancer Therapeutics
  96. Clinical applications of next generation sequencing in cancer: from panels, to exomes, to genomes
    Tony S. Shen, Stefan Pajaro-Van der Stadt, Nai Chien Yeat, Jimmy Lin · 2015 · Frontiers in Genetics
  97. The SWI/SNF complex subunit genes: Their functions, variations, and links to risk and survival outcomes in human cancers
    Sevtap Savas, Georgia Skardasi · 2018 · Critical Reviews in Oncology/Hematology
  98. Cancer systems biology of TCGA SKCM: Efficient detection of genomic drivers in melanoma
    Jian Guan, Rohit Gupta, Fabian V. Filipp · 2015 · Scientific Reports
  99. Genetic Alterations of TRAF Proteins in Human Cancers
    Sining Zhu, Juan Jin, Samantha Gokhale, Angeli M. Lu, Haiyan Shan, Jian‐Jun Feng, Ping Xie · 2018 · Frontiers in Immunology
  100. Effects of Oncogenic Gαq and Gα11 Inhibition by FR900359 in Uveal Melanoma
    Dominic Lapadula, Eduardo Farias, Clinita E. Randolph, Timothy J. Purwin, Dougan McGrath, Thomas H. Charpentier, Lihong Zhang, Shihua Wu, Mizue Terai, Takami Sato et al. · 2018 · Molecular Cancer Research